๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency

โœ Scribed by O. Butenandt; B. Staudt

Publisher
Springer
Year
1989
Tongue
English
Weight
285 KB
Volume
148
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Growth hormone therapy in achondroplasia
Growth hormone therapy in achondroplasia
โœ Horton, William A. ;Hecht, Jacqueline T. ;Hood, O. Jean ;Marshall, Robert N. ;Mo ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 451 KB ๐Ÿ‘ 2 views

A pilot study was carried out to examine the safety and efficacy of recombinant human growth hormone for growth-promoting therapy of achondroplasia. The data suggest that the agent in doses used to treat non-GH-deficient forms of short stature (0.3 mg/kg/wk) modestly increases overall height velocit

Growth hormone therapy and leukaemia
Growth hormone therapy and leukaemia
โœ N. Stahnke; H. J. Zeisel ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 611 KB

Following an initial report from Japan in 1987, 15 growth hormone (GH)-deficient patients developed leukaemia during or following GH treatment. Nearly all available pituitary and biosynthetic growth hormones have been used. In 14 of these 15 patients GH treatment was initiated in 1975 or later with

Growth-hormone releasing hormone in a br
Growth-hormone releasing hormone in a bronchial carcinoid
โœ Rudolf M. Huber; Jochen Schopohl; Marco Losa; Gernot Wolfram; Olaf Thetter; Will ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 582 KB

The case is reported of a 43-year-old patient with a peripherally located bronchial carcinoid tumor containing large amounts of immunoreactive and bioactive growth-hormone releasing hormone (GHRH). Because no GHRH was found in the peripheral circulation, there was no quantitative or qualitative dera

The effect of human growth hormone thera
The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children
โœ J. M. Wit; M. A. Hof; J. L. Brande ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 530 KB

Skinfold thickness (ST) was measured in 43 children with various forms of growth hormone (GH) deficiency during the first year of GH therapy. The average (and SEM) initial ST, expressed as standard deviation score (SDS) was 1.17 (0.25) for subscapular, 0.63 (0.18) for triceps, and 0.40 (0.21) for bi